ESC 365 - Current characteristics and treatment of patients with heart failure with reduced ejection fraction in outpatients in Europe.Baseline results of ARIADNE

ESC Premium Access

Current characteristics and treatment of patients with heart failure with reduced ejection fraction in outpatients in Europe.Baseline results of ARIADNE

Session: Late Breaking Science in Heart Failure 2

Topic: Pharmacotherapy

Speaker: Professor A. Maggioni (Florence, IT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Aldo Pietro Maggioni

Heart Care Foundation, Florence (Italy)

34 presentations

3 followers

4 more presentations in this session

Dynamic changes in cardiac structures: novel aspects of the pathophysiology of heart failure with preserved left ventricular ejection fraction -a report from the CHART-2 Study-

Speaker: Professor H. Shimokawa (Sendai, JP)

Diabetes and heart failure after acute myocardial infarction. The FAST-MI programme

Speaker: Professor N. Danchin (Paris, FR)

Natriuretic Peptide Metabolisation is Associated with Clinical Outcome in Chronic Heart Failure: a Step Towards Personalized Heart Failure Guidance

Speaker: Doctor R. van Kimmenade (Nijmegen, NL)

Association between beta-blocker use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study

Speaker: Professor G. Savarese (Stockholm, SE)

Access the full session

Late Breaking Science in Heart Failure 2

Speakers: Professor A. Maggioni, Professor H. Shimokawa, Professor N. Danchin, Doctor R. van Kimmenade, Professor G. Savarese

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources